Deep Learning-Driven Insights into Enzyme–Substrate Interaction Discovery
Journal of Chemical Information and Modeling · 13.01.2025 · 65 (1) · 187-200
DOI: 10.1021/acs.jcim.4c01801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 25.12.2024. Verfasst von Wenjia Qian und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China. Hauptthemen laut MEDLINE: Deep Learning, Enzymes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China.
ORCID-Profile: Xiaorui Wang, Yu Kang, Peichen Pan, Chang-Yu Hsieh, Tingjun Hou
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Qian, W., Wang, X., Huang, Y., Kang, Y., Pan, P., Hsieh, C. Y., & Hou, T. (2025). Deep Learning-Driven Insights into Enzyme–Substrate Interaction Discovery. Journal of Chemical Information and Modeling, 65(1), 187-200. https://doi.org/10.1021/acs.jcim.4c01801
Vancouver
Qian W, Wang X, Huang Y, Kang Y, Pan P, Hsieh CY, et al. Deep Learning-Driven Insights into Enzyme–Substrate Interaction Discovery. Journal of Chemical Information and Modeling. 2025;65(1):187-200. doi:10.1021/acs.jcim.4c01801
BibTeX
@article{Qian2025,
author = {Qian, Wenjia and Wang, Xiaorui and Huang, Yuansheng and Kang, Yu and Pan, Peichen and Hsieh, Chang-Yu and Hou, Tingjun},
title = {Deep Learning-Driven Insights into Enzyme–Substrate Interaction Discovery},
journal = {Journal of Chemical Information and Modeling},
year = {2025},
volume = {65},
number = {1},
pages = {187--200},
doi = {10.1021/acs.jcim.4c01801}
}
EUVIMED